Research News

A new protein as a target for cancer treatment

Any disruption in RNA processing by RNA binding proteins (RBPs) may lead to cancers. This research article published by Natures Communications and helmed by Associate Professor Polly Chen provides insights into the role of a cancer associated protein, DAP3, in cancer development. Findings in this research article suggests that targeting or blocking the protein DAP3 may hold great promise for cancer treatment.

Read more: https://www.nature.com/articles/s41467-022-29400-7#article-info

Share this story:
Facebook
Twitter
LinkedIn

Related Research News

Research News

Spatially Resolved, Tumour Ecosystems in Gastric Cancer Progression

Gastric cancer (GC) has significant global mortality with high heterogeneity. A study of 226 GC samples from 121 patients integrated …

Read More →
Research News

Harnessing TME: Breaking Down EMT Barriers in Cancer Treatment

The tumour microenvironment (TME) plays a pivotal role in cancer progression, metastasis, and therapeutic resistance. Comprised of diverse cells, extracellular …

Read More →
Research News

Unveiling p53’s Role in DNA Protection: New Cancer Insights

Research led by N2CR member Dr. Cheok Chit Fang found that the tumour suppressor protein p53 protects DNA during replication …

Read More →